Table 3.
Males | Females | |||||
---|---|---|---|---|---|---|
HR | CI | p | HR | CI | p | |
Neck reoperation | ||||||
No | REF | — | — | REF | — | — |
Yes | 2.90 | [2.13–3.96] | <0.001 | 6.29 | [4.86–8.14] | <0.001 |
Initial treatment | ||||||
No radioiodine | REF | — | — | REF | — | — |
Radioiodine | 0.60 | [0.47–0.75] | <0.001 | 0.88 | [0.73–1.07] | 0.22 |
Race/ethnicity | ||||||
NH white | REF | — | — | REF | — | — |
NH African American | 0.43 | [0.21–0.89] | 0.02 | 1.62 | [1.02–2.56] | 0.04 |
Hispanic | 0.95 | [0.70–1.28] | 0.72 | 1.28 | [1.00–1.64] | 0.05 |
NH Asian/Pacific Islander | 0.82 | [0.58–1.15] | 0.24 | 1.21 | [0.94–1.56] | 0.13 |
Other/unknown | 1.28 | [0.17–9.46] | 0.81 | 0.96 | [0.30–3.07] | 0.95 |
Age at diagnosis (years) | ||||||
15–34 | 0.05 | [0.03–0.11] | <0.001 | 0.01 | [0.00–0.02] | <0.001 |
35–44 | 0.12 | [0.07–0.21] | <0.001 | 0.05 | [0.03–0.08] | <0.001 |
45–54 | 0.32 | [0.21–0.49] | <0.001 | 0.13 | [0.09–0.20] | <0.001 |
55–64 | 0.51 | [0.34–0.77] | 0.001 | 0.43 | [0.32–0.59] | <0.001 |
65–74 | 0.82 | [0.57–1.17] | 0.27 | 0.63 | [0.49–0.82] | <0.001 |
≥75 | REF | — | — | REF | — | — |
Year of diagnosis | ||||||
1991–1993 | 2.00 | [1.13–3.54] | 0.02 | 2.14 | [1.28–3.59] | 0.004 |
1994–1996 | 1.87 | [1.18–2.94] | 0.007 | 1.82 | [1.24–2.69] | 0.002 |
1997–1999 | 1.75 | [1.13–2.70] | 0.01 | 1.99 | [1.39–2.84] | <0.001 |
2000–2002 | 1.08 | [0.70–1.67] | 0.72 | 1.35 | [0.93–1.95] | 0.12 |
2003–2005 | 1.16 | [0.76–1.78] | 0.49 | 1.08 | [0.75–1.57] | 0.68 |
2006–2008 | REF | — | — | REF | — | — |
Histology | ||||||
Papillary | 0.64 | [0.47–0.88] | 0.006 | 0.52 | [0.41–0.66] | <0.001 |
Follicular | REF | — | — | REF | — | — |
N stage at diagnosis | ||||||
N0 | REF | — | — | REF | — | — |
N1 | 1.25 | [0.94–1.67] | 0.13 | 1.72 | [1.35–2.20] | <0.001 |
Unknown | 1.63 | [1.14–2.31] | 0.007 | 1.68 | [1.27–2.23] | <0.001 |
M stage at diagnosis | ||||||
M0 | REF | — | — | REF | — | — |
M1 | 6.21 | [4.48–8.61] | <0.001 | 3.16 | [2.33–4.28] | <0.001 |
Unknown | 1.01 | [0.66–1.55] | 0.97 | 1.05 | [0.74–1.48] | 0.80 |
Tumor size | ||||||
<1 cm | REF | — | — | REF | — | — |
1–2 cm | 1.42 | [0.79–2.57] | 0.24 | 1.22 | [0.76–1.96] | 0.42 |
2–3 cm | 2.37 | [1.36–4.11] | 0.002 | 2.09 | [1.33–3.29] | 0.002 |
3–4 cm | 3.32 | [1.89–5.83] | <0.001 | 3.62 | [2.27–5.76] | <0.001 |
>4 cm | 5.06 | [3.03–8.45] | <0.001 | 4.47 | [2.86–6.99] | <0.001 |
Unknown | 3.92 | [2.23–6.89] | <0.001 | 4.01 | [2.51–6.39] | <0.001 |
Extrathyroidal extension | ||||||
No | REF | — | — | REF | — | — |
Yes | 3.64 | [2.75–4.80] | <0.001 | 4.32 | [3.39–5.49] | <0.001 |
Unknown | 2.28 | [1.38–3.75] | 0.001 | 2.37 | [1.52–3.71] | <0.001 |
Comorbidities at diagnosisa | ||||||
No admission ≤2 years of diagnosis | 1.80 | [1.21–2.68] | 0.004 | 1.20 | [0.88–1.64] | 0.25 |
0 | REF | — | — | REF | — | — |
1–2 | 1.37 | [0.89–2.10] | 0.15 | 1.44 | [1.04–2.00] | 0.03 |
≥3 | 2.26 | [1.30–3.92] | 0.004 | 2.09 | [1.40–3.12] | <0.001 |
Neighborhood socioeconomic status | ||||||
Low | 1.56 | [1.23–1.98] | <0.001 | 0.99 | [0.81–1.21] | 0.92 |
High | REF | — | — | REF | — | — |
Marital status | ||||||
Never married | 1.02 | [0.73–1.44] | 0.90 | 0.91 | [0.65–1.26] | 0.56 |
Previously married | 0.92 | [0.63–1.35] | 0.67 | 1.18 | [0.95–1.47] | 0.13 |
Married | REF | — | — | REF | — | — |
Unknown marital status | 1.39 | [0.61–3.17] | 0.43 | 1.73 | [0.97–3.10] | 0.07 |
Health insurance at diagnosis | ||||||
No insurance/self-pay | 0.88 | [0.38–2.07] | 0.77 | 1.45 | [0.75–2.79] | 0.27 |
Private | REF | — | — | REF | — | — |
Medicaid/government | 1.16 | [0.73–1.84] | 0.54 | 1.53 | [1.07–2.19] | 0.02 |
Medicare | 1.14 | [0.83–1.56] | 0.42 | 1.08 | [0.83–1.40] | 0.55 |
Unknown insurance | 0.53 | [0.34–0.82] | 0.005 | 0.69 | [0.47–1.03] | 0.07 |
Hospital thyroidectomy volumeb | ||||||
Low | REF | — | — | REF | — | — |
High | 1.06 | [0.82–1.36] | 0.66 | 0.92 | [0.74–1.13] | 0.42 |
Unknown | 1.30 | [0.90–1.88] | 0.16 | 1.09 | [0.79–1.51] | 0.58 |
Exlihauser comorbidity index diagnosis or two years prior to diagnosis, cancer was excluded as a comorbidity.
High-volume thyroidectomy hospital defined as the top 10% of hospitals performing thyroidectomies.
HR, hazard ratio.